WEBINAR: Bridging the gap: using organ-on-a-chip as an experimental tool to develop (cost) effective therapeutics – Tuesday, 26 September 2023

cnb887 dtr webinar promo bar v1 |
Register here
cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo
  • Products
    • Explore our solutions


      PhysioMimix® products enable you to recreate complex human biology and accurately predict human drug responses

      PhysioMimix OOC

      PhysioMimix OOC systems
      Learn more

      Consumables

      • Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
      Learn more

      Models

      • Single-organ models
      • Liver-on-a-chip model
      • Multi-organ models

      Support packages

      • PhysioMimix® support packages
  • Applications
    • Discover the applications


      Investigate the application areas that our PhysioMimix® products and services support

      Learn more

      Disease modeling

      • Non-Alcoholic Steatohepatitis
      • Hepatitis B
      • COVID-19
      Learn more

      Safety toxicology

      • Drug-induced liver injury
      • Immune-mediated toxicities
      Learn more

      ADME

      • Drug absorption
      • Drug metabolism
      • Drug bioavailability
      Learn more
  • Services
    • Studies as a service


      Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

      Learn more
      NAFLD / NASH icons

      NAFLD / NASH

      Drug-induced liver injury icon

      Drug-induced liver injury

      icon adme |

      ADME

  • Resources
  • Company
    • About us


      Meet the team, explore our culture and discover what to expect when working with us

      CN Bio team photo
      About us

      Latest news

      • A guide to pre-validating cells for use in Organ-on-a-chip assays

      • CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

      • CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer

      View all news

      Upcoming Events

      • AASLD 2023

      • EUROTOX 2023

      View all events

      Join the team!

      • Content Marketing Manager

      • Senior Scientist R&D

      View all jobs
  • Contact
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers
  • Contact
  • Skip to main content
  • Skip to footer
Chat live with an expert

Speak to an expert about NASH-in-a-box

Enquire

PhysioMimix® consumables

NASH-in-a-box


Fast-track your route to successful therapeutic development with our in vitro 3D NASH model

niab loog on dark v2 |

NASH-in-a-box contains everything required to recreate our industry-validated human in vitro Non-Alcoholic Steatohepatitis (NASH) model in your own laboratory.

It is designed for use with our PhysioMimix OOC range of single- and multi-organ microphysiological systems.

Watch the short animation (look right) which describes how our NASH-in-a-box kit enhances your chance of successfully developing NASH therapeutics by recreating our industry-proven 3D NASH model in your laboratory.

NASH-in-a-box supports:

cnb icons stopwatch |

The rapid adoption of an organ-on-a-chip approach by scientists, irrespective of their experience

icon nash 1 |

Instant access to validated protocols developed and refined through years of industry collaboration

icon data |

Generation of high-content clinically translatable data to unlock disease mechanisms and confirm drug efficacy and safety

Features of our 3D NASH model kit

Use NASH-in-a-box to address the limitations of traditional approaches and avoid unexpected results in the clinic.

  • PhysioMimix OOC compatible and fully supported
  • Software-guided protocols
  • 3D validated primary human hepatocytes, stellate, and Kupffer cells
  • Proprietary NASH media and supplements
  • ELISA quality control kits (albumin/cytotoxicity) to test microtissue health and function
  • Guaranteed  for 14 days of culture
  • 10-month shelf life (from manufacture)

*Some geographical regions may have legislation for storing human cells requiring a license.


LifeSciences 2022 |

Cells sourced from LifeNetHealth LifeSciences or Lonza


niab |
    Watch animation

NASH-in-a-box Animated Video

What’s in the box?

Media

MediaVolume
Hepatocyte thawing media50 mL
Basal media (HEP-Fat)500 mL
Basal media (HEP-Stellate)250 mL
Basal media (HEP-Seeding)250mL

Assay kits

Quality control. assay kitsNumber of kits
Assaypro Human Albumin AssayMax ELISA Kit2 kits
Promega CytoTox 96 Cytotoxicty (LDH) Assay Kit1 kit

PhysioMimix plates

Multi-chip plates  Number of plates/replicates
Multi-chip Liver-12+ plate (MPS-LC12+) 2 plates /24 replicates  

Supplements

SupplementsVolume
HEP- Supplement A5 x 2.5 mL
HEP Supplement B1 x 250 µL  
HEP- Supplement C1 x 500 µL  
HEP- Supplement D1 x 500 µL  
Hydrocortisone5 x 5 µL  
TGF – Beta5 x 200 µL  

Primary human cells

Primary human cells*Number of vials (cells/vial)  
Hepatocytes2 vials (min 5M/via)
Kupffer cells2 vials (min 500K/vial)
Stellate cells1 vial (min 100K /vial)

*Contact us should you require specific donor characteristics or pooled donors.

niab report v4 1 |

Validation report


Our sample report describes the extensive process of validating donor cell combinations within NASH-in-a-box.

Our quality control procedures ensure the formation of stable three-dimensional liver microtissues that demonstrate a NASH phenotype when cultured over 14 days.

Download sample report (PDF)

Guided software


Located on the PhysioMimix Controller, guided software provides step-by-step instructions for culturing liver microtissues and inducing the NASH phenotype.

By guiding users through the process, it enables operators with limited experience to use the NASH-in-a-box kit with confidence.

niab ui |
niab data sheets |

Safety data sheets


Basal medium (PDF)

Supplement A (PDF)

Supplement B (PDF)

Supplement C (PDF)

Supplement D (PDF)

Hydrocortisone (PDF)

TGF Beta 1 protein (PDF)

How does our 3D NASH model compare?

There is a wide range of preclinical research and development tools available.

How does NASH‑in‑a‑box compare to more traditional approaches?

In vitro 2D cell cultureIn vitro 3D spheroidIn vivo animal modelsNASH-in-a-box
Human relevance
Data contentLOWMEDIUMHIGHHIGH
Longevity< 7 days< 7 days> 4 weeks2 weeks
Model complexity
Throughput
Ease of adoption
Cost$$$$$$$
Time to result
NASH phenotype

Frequently asked questions

How do I order a NASH-in-a-box kit?

Please click on the Request a quote link on this page and fill out the short form. A member of our expert team will contact you directly.

Do you provide healthy/lean media for use with your NASH 3D model?

We do not provide healthy/lean media in the NASH-in-a-box kit as stellate cells cultured on plasticware become activated and generate a level of fibrosis regardless of the media. CN Bio’s NASH media, however, pushes the fibrosis response beyond baseline Stellate activation. This means that data normalized to a healthy/lean media control would be skewed versus a truly healthy liver microtissue. To circumvent this, CN Bio uses positive controls e.g., Elafibranor to compare therapeutic efficacy versus the negative control of the NASH phenotype.

Which cell lines were used to create the 3D NASH model?

To ensure that we recreate an in vitro model that is as human relevant as possible, cell lines (also known as immortalized cells), are not used. Instead, we use primary cells to generate physiologically relevant liver microtissues that more accurately recapitulate the disease phenotype.

Where do you source the primary human cells in your 3D NASH model?

Our cells are sourced from LifeNet Health LifeSciences, or Lonza and then thoroughly validated by CN Bio prior to inclusion in the kit. The process of validating cell lots for use in MPS assays is necessary to ensure data robustness and reliability. However, this process is costly and time-consuming. By providing customers with convenient, off-the-shelf, pre-validated reagents, we remove this burden – enabling researchers to focus their efforts on making new discoveries. Click here for more information about our wider portfolio of 3D validated cells and why cell validation ahead of organ-on-a-chip assays is critical to their success.

Can we adapt your protocol to run longer 3D NASH model cultures?

The model has been validated for 14 days of culture. The volumes of media and supplements supplied within the kit reflect this timeframe. Extending the experiment may be possible but has yet to be validated. Should you wish to register your interest, contact us.

Can you provide genotype data for the cells within the NASH-in-a-box kit?

Yes. We assess each qualified donor for key NASH-related genes. Please contact us to discuss your requirements.

What endpoints can you measure from your 3D NASH model?

NASH-in-a-box enables deep insights to be gathered from each microtissue, providing researchers with an in vitro experimental tool to study the mechanism of disease or anti-NASH drug treatments.

Approximately 1 mL of media can be removed from every media exchange. We recommend using the assay kits supplied to measure hepatic function and microtissue health (albumin & LDH) at each media exchange. Exchanged media can also be used to analyze soluble biomarkers of your choice throughout the experiment, such as interleukin-6 (IL-6) or tissue inhibitor of metalloproteinase I (TIMP-1). IL-6 is an excellent marker of the inflammatory response of NASH, while markers such as TIMP-1 and fibronectin can be used to assess fibrosis.

At the end of the experiment, microtissues can be recovered for microscopy analysis, quantitative PCR, and transcriptomics studies. The scaffold on which cells are seeded can be cut in half. One half of the recovered microtissue can be used for -omics or adenosine triphosphate (ATP) content quantification, and the other half can be fixed for immunofluorescence assays (IFA) using confocal microscopy.

A list of routinely used endpoint measurements can be found on our NASH applications page, however, we have tested many other disease biomarkers, so please contact us if your endpoint(s) of interest is/are not listed.

Are the cells in your 3D NASH model all from the same donor?

In an ideal world this would be the case, however, it is currently not possible to source all three cell types from the same donor. We thoroughly validate the performance of cells in tri-culture prior to supplying them in the kit.

Describe the process for validating the cells provided in your 3D NASH model kit?

You can find a sample validation report on this page that details the qualification protocol that we adhere to.

In short, primary human hepatocytes (PHHs) are first validated alone to verify 3D microtissue formation and acceptable function. Validated, PHHs are subsequently tested with Kupffer cells and stellate cells under NASH conditions to ensure good cell-cell interaction and disease phenotype using our bespoke NASH media.

Can you add additional cell types into the 3D NASH model?

We can only guarantee the performance of the NASH-in-a-box kit using the cells supplied. The cells within each kit have been thoroughly tested to ensure that they form 3D, highly functional microtissues that exhibit a NASH disease phenotype when cultured using our bespoke NASH media.

By using the kit, you benefit from years of CN Bio R&D expertise, validation of the 3D NASH model via industry collaboration, and carefully quality-controlled reagents that ensure reliable, robust, and reproducible performance. Our NASH-in-a-Box kit enables those who are new to the organ-on-a-chip (OOC) field to “hit the ground running” and fast-track their research.

However, should you want to develop your own 3D NASH model, or customize our tri-culture model to incorporate additional cell types, our PhysioMimix® OOC range of microphysiological systems and Multi-chip Liver plates offer the flexibility and versatility to do so. Where possible, we would recommend purchasing cells from our 3D validated cell portfolio to shorten R&D timelines and minimize cost. Note: Stellate cells are only available for purchase within a NASH-in-a-box kit.

Can you tell me more about the software guided protocols?

Our software guided protocol can be found on the PhysioMimix Controller Unit. It complements the Standard Operating Procedure (SOP) provided within the kit by providing step by step instructions for culturing over 14 days. The software will only allow the protocol to proceed once a user has confirmed that an action has been performed to prevent user error. By guiding users through the process, it enables any operator, irrespective of experience, to use the NASH-in-a-box kit with confidence.

Can NASH-in-a-box kits be used on an alternative Organ-on-a-chip Systems?

NASH-in-a-box has been designed for, and validated using, the PhysioMimix OOC range of microphysiological systems. The Multi-chip Liver-12+ plates are for sole use with the NASH-in-a-box kit and are incompatible with other Organ-on-a-chip systems. Therefore, it would not make sense to purchase the kit for use with an alternative solution.

Do you supply a pool of donors or single donor for the PHH?

The PHHs supplied in the kit are from single donors that have been thoroughly validated for use in 3D organ-on-a-chip (OOC) cultures. Not all PHH donors cope well with 3D OOC cell culture or the NASH media. The former may explain why pooled hepatocytes generally perform poorly in organ-on-a-chip systems and is the reason why we provide 3D validated cells within our solutions portfolio.

As using pooled donors increases the risk of experimental failure, we recommend requesting different donor lots and testing these individually to overcome/assess donor to donor variability. The number of individual donors’ lots that we have in our validated tri-culture catalog varies depending on availability, however, we will do our best to accommodate your needs.

Why is the media important? What is in it?

Our bespoke NASH media represents a fatty diet. It contains various free fatty acids (FFA) and sugars. Perfusion of liver microtissues with NASH media induces fat loading (steatosis) that leads to inflammation and fibrosis, thereby recapitulating human disease progression in vitro.

The recipe of media constituents is complex and has been developed over many years of R&D. When used in conjunction with PhysioMimix OOC Systems, NASH-in-a-box provides an off-the shelf solution to quickly, simply and confidently recreate the human NASH disease so that researchers can focus their time developing much-needed therapeutics for this widespread disease.

Are shipping costs included?

Shipping costs are not included as they may vary depending on the number of kits ordered or split shipment requests. Shipping costs will be added as a line item in any quote requests.

How do I store my kit(s)?

ItemStorage conditions
Basal media (HEP-Fat)+4°C
Basal media (HEP-Stellate)+4°C
Basal media (HEP-Seeding)+4°C
HEP-Supplement A+4°C
HEP-Supplement B-20°C
HEP-Supplement C-20°C
HEP-Supplement D-20°C
Hydrocortisone-20°C
TGF-β-20°C

Included (separate shipment)

ItemStorage conditions
Primary Human Hepatocytes-196°C
Kupffer Cells-196°C
Human Stellate Cells-196°C
Human Cryopreserved Hepatocyte Thawing Medium (HHTM)-20°C

Not included

ItemStorage conditions
Foetal bovine serum (FBS)+4°C
Bovine serum albumin 35% in DPBS (BSA solution)+4°C
Bovine serum albumin (fatty-acid-free BSA)+4°C
0.2 µm aPES membrane filterRoom Temperature (RT)

If you do not find the answer to your question listed, please contact us

Featured resources

Infographic

My project 1 24 |

Pros and cons of preclinical models of Non-Alcoholic Steatohepatitis

Podcasts

My project copy 1 1 |

Organ-on-a-Chip Models of Fatty Liver Disease

Webinars

cnb653 dash for nash resource |

The Dash for NASH

Speak to our experts

Speak directly with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Terms | Regulatory | Accessibility

Product Recycling

©2023 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • A guide to pre-validating cells for use in Organ-on-a-chip assays September 5, 2023
  • CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems September 5, 2023
  • CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer August 30, 2023

Upcoming events

AASLD 2023 November 10-14, 2023

EUROTOX 2023 September 10-13, 2023